Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction. [electronic resource]
Producer: 20151027Description: 287-92 p. digitalISSN:- 1440-1681
- Gene Expression Regulation -- drug effects
- Human Umbilical Vein Endothelial Cells -- cytology
- Humans
- Indican -- toxicity
- MAP Kinase Signaling System -- drug effects
- Mitogen-Activated Protein Kinases -- metabolism
- NF-kappa B -- metabolism
- Oxidative Stress -- drug effects
- Rosiglitazone
- Thiazolidinediones -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.